CD34-selected stem cell transplantation offers long-term survival for patient with advanced MDS.
CD34-selected stem cell transplantation has low incidence of acute and chronic GVHD.
Relapse rates after CD34-selected stem cell transplantation are not higher compared with unmodified transplants.
Infections are the main cause of mortality after CD34-selected stem cell transplantation.